Stimuli-responsive peptide-based nanodrug delivery systems for tumor therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Drug Delivery

Background:

• Nano-sized drug delivery systems show enhanced therapeutic effects and reduced toxicity over free chemotherapeutic drugs.
• Peptide-based systems are attractive due to biocompatibility, functional diversity, and structural stability.
• Stimuli-responsive elements can be incorporated into peptide side chains for targeted drug release.

Purpose of the Study:

• To review recent advancements in peptide-based nanodrug delivery systems.
• To summarize the mechanisms of stimuli-responsive peptide nanodrug delivery.
• To outline future challenges in the field.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of mechanisms underlying stimuli-responsive peptide nanodrugs.
• Synthesis of information on current challenges and future directions.

Main Results:

• Peptide-based nanodrugs demonstrate significant potential for targeted drug delivery.
• Stimuli-responsive features enable controlled drug release in response to internal or external triggers.
• These systems offer a promising platform for overcoming limitations of conventional chemotherapy.

Conclusions:

• Peptide-based nanodrug delivery systems represent a significant advancement in therapeutic strategies.
• Further research is needed to address challenges in clinical translation and large-scale production.
• The field holds promise for developing more effective and safer cancer treatments.